A recent article written by Llewellyn King discusses crowd-sourcing’s newest application: clinical drug trials. Traditional drug trials are not terribly efficient at actually helping patients who are suffering from a particular disease. These trials are lengthy and expensive, and the control group is often treated with a placebo or nothing at all. What’s worse is that the knowledge gained from such trials is Read More